News

The two-year study showed that by using Applied NeuroSolutions’ test, which measures the amount of an abnormal protein, called p-tau in conjunction with current methods to diagnose Alzheimer’s,

In a breast cancer model, ENMD-1198 was shown to inhibit a protein called HIF-1alpha which is over-expressed in more than 70% of human tumors. This over-expression correlates with

The companies agreed Transgene would be paid a fixed total amount, with installments made at specified times over the life of the contract to produce the Innogenetics vaccine.

The objectives of the trial are to evaluate the safety, toxicity, pharmacokinetic profile and initial clinical activity of KP-1461. The trial is being conducted at several HIV treatment

Despite this perception, many adults aged 55 and over have one or more factors that put them at increased risk for stomach ulcers that can result from chronic

The phase II proof-of-concept study demonstrated clinically meaningful and statistically significant improvement in the primary endpoint, the international prostate symptom score (IPSS), a seven-item questionnaire that assesses the

The trial involves priming an immune response with multiple doses of a plasmid DNA vaccine, based on Vical’s proprietary DNA delivery technology, and boosting the response with a

The ruling is the result of a lawsuit brought by the generic manufacturer Ranbaxy, which challenged two patents protecting Lipitor. The court ruled that a Ranbaxy generic would

The double-blind, placebo-controlled phase II study will enroll a total of 480 healthy volunteers, who will be randomized to receive either vaccine or placebo. The treatment group will